The Future of Combination Therapy in Melanoma

Speaker: Ulrich Keilholz

U. Keilholz says the combination treatment in melanoma comprises of combination of targeted agents or combination of targeted therapy and immunotherapy. The targeted therapy offers faster response, while immunotherapy works slow in induction phase, but provides more durable response. These facts translates into current thinking in treatment scenarios; furthermore, he elaborates perspective of studying the right therapy sequence.

Discussion Points

  • What is the future of combination treatment in melanoma?
  • Characteristics of response to targeted therapy, immunotherapy, combination treatment
  • What may the ongoing studies in advanced melanoma answer in the future?